Zevra Therapeutics, Inc. ZVRA Business Segments — Other Nonoperating Income (Expense)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s business segments — other nonoperating income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s business segments — other nonoperating income (expense)?
- Zevra Therapeutics, Inc. (ZVRA) reported business segments — other nonoperating income (expense) of $33.65M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s business segments — other nonoperating income (expense) changed year-over-year?
- Zevra Therapeutics, Inc.'s business segments — other nonoperating income (expense) increased by 894.2% year-over-year, from $3.39M to $33.65M.
- What does business segments — other nonoperating income (expense) mean?
- Includes miscellaneous income or expenses that fall outside the scope of the segment's primary operating activities, such as gains or losses from asset sales or currency fluctuations. This metric helps isolate core operational performance from transient or non-recurring financial events.